Biosysen HY FY26 profit attributable to owners swings to HK$21.15 million; revenue slips 1.4% to HK$25.09 million

• Biosysen posted profit attributable to owners of HK$21.15 million for the six months ended June 30, returning to profit from a loss.
• Revenue slipped 1.4% to HK$25.09 million, with healthcare and beauty rising to HK$16.2 million while accommodation revenue fell to HK$8.88 million.
• Operating profit swung to HK$54.77 million, driven by a HK$65.79 million gain on early lease termination.
• Average occupancy rate fell 3.5 percentage points to 47.7%, with ARR down to RMB 204.9 and RevPAR down to RMB 97.7.
• Completed a HK$22 million purchase of a 37.5% stake in Beisheng Biotechnology, aiming to cut R&D costs and speed commercialization.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biosysen Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260831-12309778), on August 31, 2026, and is solely responsible for the information contained therein.